Variant report

Variant	nsv960384
Chromosome Location	chr17:20827680-20830644
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr17:20828477-20828663	K562	blood:	n/a	n/a
2	CEBPB	chr17:20828428-20828767	A549	lung:	n/a	n/a
3	CEBPB	chr17:20828417-20828777	A549	lung:	n/a	n/a
4	CEBPB	chr17:20828450-20828801	K562	blood:	n/a	n/a
5	CEBPB	chr17:20828431-20828784	HepG2	liver:	n/a	n/a
6	CEBPB	chr17:20828379-20828799	IMR90	lung:	n/a	n/a
7	CEBPB	chr17:20828412-20828788	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr17:20828482-20828681	MCF-7	breast:	n/a	n/a
9	CEBPB	chr17:20828410-20828771	K562	blood:	n/a	n/a
10	EP300	chr17:20829661-20830260	SK-N-SH	brain:	n/a	n/a
11	FOS	chr17:20828438-20828786	MCF10A-Er-Src	breast:	n/a	chr17:20828599-20828607 chr17:20828598-20828609
12	FOS	chr17:20828440-20828787	MCF10A-Er-Src	breast:	n/a	chr17:20828599-20828607 chr17:20828598-20828609
13	FOS	chr17:20828425-20828787	MCF10A-Er-Src	breast:	n/a	chr17:20828599-20828607 chr17:20828598-20828609
14	FOS	chr17:20828386-20828787	MCF10A-Er-Src	breast:	n/a	chr17:20828599-20828607 chr17:20828598-20828609
15	GATA3	chr17:20829702-20830239	SK-N-SH	brain:	n/a	n/a
16	GATA3	chr17:20829693-20830376	SK-N-SH	brain:	n/a	n/a
17	JUND	chr17:20829771-20830371	SK-N-SH	brain:	n/a	n/a
18	MEF2A	chr17:20829740-20830356	SK-N-SH	brain:	n/a	chr17:20830081-20830096 chr17:20830122-20830133 chr17:20830081-20830096 chr17:20830119-20830135 chr17:20830120-20830135 chr17:20830120-20830135
19	MEF2A	chr17:20829762-20830272	SK-N-SH	brain:	n/a	chr17:20830081-20830096 chr17:20830122-20830133 chr17:20830081-20830096 chr17:20830119-20830135 chr17:20830120-20830135 chr17:20830120-20830135
20	MYC	chr17:20828451-20828746	MCF10A-Er-Src	breast:	n/a	n/a
21	NFE2	chr17:20829988-20830064	GM12878	blood:	n/a	n/a
22	NFIC	chr17:20829621-20830331	SK-N-SH	brain:	n/a	n/a
23	PBX3	chr17:20829699-20830354	SK-N-SH	brain:	n/a	n/a
24	PBX3	chr17:20829743-20830222	SK-N-SH	brain:	n/a	n/a
25	POLR2A	chr17:20829756-20830219	SK-N-SH	brain:	n/a	n/a
26	POLR2A	chr17:20827824-20827891	MCF-7	breast:	n/a	n/a
27	POLR2A	chr17:20830467-20830586	MCF10A-Er-Src	breast:	n/a	n/a
28	POLR2A	chr17:20827806-20827872	A549	lung:	n/a	n/a
29	SPI1	chr17:20829336-20829536	GM12891	blood:	n/a	n/a
30	SPI1	chr17:20829275-20829582	GM12891	blood:	n/a	n/a
31	TCF12	chr17:20829606-20830419	SK-N-SH	brain:	n/a	chr17:20829903-20829910
32	TCF12	chr17:20829666-20830318	SK-N-SH	brain:	n/a	chr17:20829903-20829910
33	TEAD4	chr17:20829663-20830371	SK-N-SH	brain:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:20828074..20830327-chr17:20832191..20833842,2	K562	blood:
2	chr17:20828074..20830822-chr17:20831335..20835053,4	K562	blood:
3	chr17:20830020..20832888-chr17:20849310..20850863,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHRS7B-5	chr17:20827672-20828146	ENSG00000233098.3
2	lnc-DHRS7B-5	chr17:20827672-20828146	XLOC_012139
3	lnc-DHRS7B-5	chr17:20827672-20827738	ENSG00000233098.3

Variant related genes	Relation type
ENSG00000233098	TF binding region
ENSG00000233098	chromatin interactions
PIWIL4	miRNA target sites

Extended variants
information (count: 94 )
Associated
traits (count: 150 )

Variant overlapped rSNPs/rCNVs (count:94 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs371090075	chr17:20827686-20827687	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
2	rs547216153	chr17:20827712-20827713	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
3	rs533426641	chr17:20827720-20827721	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
4	rs145141165	chr17:20827731-20827732	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
5	rs373115171	chr17:20827735-20827736	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
6	rs567027846	chr17:20827760-20827761	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
7	rs149109820	chr17:20827764-20827765	Weak transcription Strong transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
8	rs570708811	chr17:20827803-20827804	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
9	rs538344320	chr17:20827834-20827835	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
10	rs556346285	chr17:20827892-20827893	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
11	rs574997051	chr17:20827893-20827894	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs374405041	chr17:20827937-20827938	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
13	rs184432503	chr17:20827950-20827951	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
14	rs200269151	chr17:20827953-20827954	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
15	rs142080485	chr17:20827955-20827956	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs113867713	chr17:20827982-20827983	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs546088183	chr17:20828002-20828003	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs75946413	chr17:20828043-20828044	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs564901496	chr17:20828048-20828049	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs531973856	chr17:20828148-20828149	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs544312511	chr17:20828172-20828173	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs562416202	chr17:20828173-20828174	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs552806603	chr17:20828186-20828187	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs141086284	chr17:20828252-20828253	Weak transcription Strong transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs146959748	chr17:20828340-20828341	Weak transcription Strong transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs566668516	chr17:20828347-20828348	Weak transcription Strong transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs527585644	chr17:20828350-20828351	Weak transcription Strong transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs552459200	chr17:20828359-20828360	Weak transcription Strong transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs569427554	chr17:20828370-20828371	Weak transcription Strong transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs570838707	chr17:20828418-20828419	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs537820424	chr17:20828422-20828423	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs550123898	chr17:20828425-20828426	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs568491757	chr17:20828426-20828427	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs566745167	chr17:20828429-20828430	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs535547019	chr17:20828443-20828444	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs137962148	chr17:20828471-20828472	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs115211820	chr17:20828491-20828492	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs539755096	chr17:20828567-20828568	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs17841430	chr17:20828570-20828571	Weak transcription Strong transcription Active TSS Enhancers	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs142583009	chr17:20828621-20828622	Weak transcription Strong transcription Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs111648573	chr17:20828665-20828666	Weak transcription Strong transcription Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs201727313	chr17:20828721-20828722	Weak transcription Strong transcription Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs567714608	chr17:20828735-20828736	Weak transcription Strong transcription Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs562489362	chr17:20828837-20828838	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs77961852	chr17:20828937-20828938	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs541899156	chr17:20829025-20829026	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs188920605	chr17:20829122-20829123	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs560396951	chr17:20829165-20829166	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs527446684	chr17:20829204-20829205	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs570271599	chr17:20829259-20829260	Weak transcription Strong transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:150)

Disease	PMID	Source
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:67 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20812600-20830800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
2	chr17:20820200-20827800	Weak transcription	Right Atrium	heart
3	chr17:20823400-20831600	Weak transcription	Colon Smooth Muscle	Colon
4	chr17:20823400-20833600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr17:20825000-20827800	Weak transcription	Ovary	ovary
6	chr17:20826000-20827800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr17:20826000-20829000	Weak transcription	NHLF	lung
8	chr17:20826000-20829200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr17:20826000-20830800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
10	chr17:20826000-20837800	Weak transcription	K562	blood
11	chr17:20826200-20828800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr17:20826200-20829000	Weak transcription	HMEC	breast
13	chr17:20826200-20829000	Weak transcription	HSMM	muscle
14	chr17:20826200-20829000	Weak transcription	Osteobl	bone
15	chr17:20826200-20829200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr17:20826200-20829200	Weak transcription	A549	lung
17	chr17:20826200-20829200	Weak transcription	NH-A	brain
18	chr17:20826400-20829000	Weak transcription	Muscle Satellite Cultured Cells	--
19	chr17:20826400-20834800	Weak transcription	HepG2	liver
20	chr17:20826400-20837000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr17:20826600-20837200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr17:20826800-20827800	Weak transcription	NHDF-Ad	bronchial
23	chr17:20826800-20829200	Weak transcription	HSMMtube	muscle
24	chr17:20826800-20835200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr17:20827000-20837000	Weak transcription	Hela-S3	cervix
26	chr17:20827200-20856200	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr17:20827400-20827800	Enhancers	HUVEC	blood vessel
28	chr17:20827600-20828000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr17:20827600-20829400	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
30	chr17:20827800-20828200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
31	chr17:20827800-20828200	Flanking Active TSS	Ovary	ovary
32	chr17:20827800-20828600	Enhancers	NHDF-Ad	bronchial
33	chr17:20827800-20829600	Active TSS	Right Atrium	heart
34	chr17:20828000-20829000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr17:20828200-20829000	Weak transcription	Ovary	ovary
36	chr17:20828200-20833400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
37	chr17:20828600-20829000	Weak transcription	NHDF-Ad	bronchial
38	chr17:20828800-20829800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr17:20829000-20829400	Enhancers	Primary B cells from peripheral blood	blood
40	chr17:20829000-20829400	Active TSS	Ovary	ovary
41	chr17:20829000-20829400	Enhancers	HMEC	breast
42	chr17:20829000-20829600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr17:20829000-20830600	Enhancers	HSMM	muscle
44	chr17:20829000-20830800	Enhancers	Osteobl	bone
45	chr17:20829000-20831000	Enhancers	NHDF-Ad	bronchial
46	chr17:20829000-20831200	Enhancers	Muscle Satellite Cultured Cells	--
47	chr17:20829000-20831200	Enhancers	NHLF	lung
48	chr17:20829200-20829600	Enhancers	A549	lung
49	chr17:20829200-20830000	Enhancers	NH-A	brain
50	chr17:20829200-20830200	Enhancers	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links